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MaOBJECTIVES The goal of this study was to examine the calibration of a validated risk-adjustment model in very high-
risk percutaneous coronary intervention (PCI) cases and assess whether sites’ case mix affects their performance ratings.
BACKGROUND There are concerns that treating PCI patients with particularly high-risk features such as cardiogenic
shock or prior cardiac arrest may adversely impact hospital performance ratings. However, there is little investigation on
the validity of these concerns.
METHODS We examined 624,286 PCI procedures from 1,168 sites that participated in the CathPCI Registry in 2010.
Procedural risk was estimated using the recently published Version 4 National Cardiovascular Data Registry (NCDR) PCI
risk-adjusted mortality (RAM) model. We calculated observed/expected mortality using several risk classiﬁcation
methods, and simulated hospital performance after combining their highest risk cases over 2 years into a single year.
RESULTS In 2010, crude in-hospital PCI mortality was 1.4%. The NCDR model was generally well calibrated among high
risk, however there was slight overprediction of risk in extreme cases. Hospitals treating the highest overall expected
risk PCI patients or those treating the top 20% of high-risk cases had lower (better) RAM ratings than centers treating
lower-risk cases (1.25% vs. 1.51%). The observed/expected ratio for top-risk quintile versus low-risk quintile was 0.91
(0.87 to 0.96) versus 1.10 (1.03 to 1.17). Combining all the high-risk patients over a 2-year period into a single year also
did not negatively impact the site’s RAM ratings.
CONCLUSIONS Evaluation of a contemporary sample of PCI cases across the United States showed no evidence that
treating high-risk PCI cases adversely affects hospital RAM rates. (J Am Coll Cardiol Intv 2015;8:10–6) © 2015 by the
American College of Cardiology Foundation.m the *Division of Cardiovascular Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, North
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AB BR E V I A T I O N S
AND ACRONYM S
CI = conﬁdence interval
NCDR = National
Cardiovascular Data Registry
O/E ratio = observed versus
expected mortality ratio
PCI = percutaneous coronary
intervention
RAM = risk-adjusted mortality
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11H ospital quality is now judged by severalmetrics. A common measure for hospitaloutcomes is risk-adjusted mortality (RAM)
(1,2), which is calculated for many different cli-
nical conditions, including percutaneous coronary
intervention (PCI). Historically, these risk-
adjustment models have their basis in the belief
that mortality, if appropriately adjusted for case
mix, is a measure of overall hospital quality (3). Hos-
pitals and providers have voiced concerns that
risk-adjustment models employed to account for
case mix may not adequately account for particularly
high-risk clinical features (4,5), and that clinicians
and hospitals treating a greater number of high-risk
patients may have a worse rating (6). At worst, these
concerns might lead clinicians to avoid very high-risk,
but appropriate-to-treat, patients in order to protect
their RAM ratings (7,8).FIGURE 1 Study Sample Selection Diagram
The ﬂow diagram shows the derivation of the study population. NCDR ¼ National Car-
diovascular Data Registry; PCI ¼ percutaneous coronary intervention.
SEE PAGE 17PCI is a commonly performed procedure, occurring
at approximately 1,700 medical centers in the United
States (9). These centers have a wide variation in
hospital volume and case mix (10), hence RAM rat-
ings are a commonly used, though controversial,
quality measure. Cardiac arrest and cardiogenic
shock patients represent the highest-risk patients
potentially treated by PCI. These 2 groups of patients
have the highest in-hospital mortality, but may also
have the highest potential beneﬁt from urgent
percutaneous revascularization (11–15). PCI practice
patterns in the United States show signiﬁcant vari-
ability for patients with cardiac arrest and cardio-
genic shock, and recent data indicate that public
reporting of performance measures may partially
drive the differences seen in these practice patterns
(16). A possible explanation for these data is that PCI
practitioners may change their behavior (become
more risk avoidant) to avoid a negative impact on
their RAM ratings. There has been signiﬁcant docu-
mentation of these concerns (17) and even observa-
tional evidence of shifts in PCI and surgical practice
patterns (8,18).
Our study aimed to evaluate the accuracy of a
validated and widely used risk adjustment model
from the National Cardiovascular Data Registry
(NCDR) CathPCI registry, the current NCDR PCI
RAM model, to estimate mortality in moderate- and
high-risk subsets. We then aimed to assess whether
sites treating more high-risk cases have worse
observed versus expected mortality ratios and
worse RAM ratings than sites treating lower-risk
patients.METHODS
The CathPCI Registry is a collaborative effort
of the American College of Cardiology Foun-
dation and the Society for Cardiovascular
Angiography and Interventions, and remains
the largest ongoing registry of PCI in the
United States. Descriptions of the registry
have been previously published (9). The reg-
istry collects data on patient and hospital
characteristics, clinical presentation, proce-
dural characteristics, and in-hospital outcomes for
PCI procedures from >1,200 sites across the United
States. Data are entered into NCDR-certiﬁed software
at participating institutions, and exported in a stan-
dard format to the American College of Cardiology.
There is a comprehensive data quality program,
including both data quality report speciﬁcations for
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12data capture and transmission, as well as an auditing
program (19).
STUDY POPULATION. All PCI procedures in the NCDR
CathPCI registry in calendar year 2010 were initially
included. We excluded those procedures that were
repeat procedures in a patient, that were transferred
to another facility after the procedure, those with
unknown vital status, and those hospitals whose
annual volume was <50 PCIs. This resulted in a ﬁnal
study population of 624,286 PCI procedures at 1,168
hospitals (Figure 1).ion Plots for Mortality Risk
the full spectrum of mortality risk (A) and in high-risk subgroups of
lvage percutaneous coronary intervention (PCI) patients (B) are
versus expected mortality plots show good calibration of the CathPCI
l spectrum of risk in PCI patients. Carshock ¼ cardiogenic shock.OUTCOMES AND CURRENT RISK MODEL. The primary
outcome evaluated in this study was in-hospital
mortality. The current, Version 4 NCDR PCI RAM
model has been recently described in detail (20).
Brieﬂy, the current model was based upon the ﬁnd-
ings in over 1 million PCI patients seen between mid-
2009 and mid-2011, and includes 18 clinical variables.
It was developed in 60% of the total population, and
validated in the remaining 40% of the study popula-
tion. The model showed excellent discriminative
ability, with a c-index of 0.93. It also showed good
calibration with a Hosmer-Lemeshow goodness-of-ﬁt
statistics p value of <0.05.
STATISTICAL METHODS. As previously described,
the predicted in-hospital mortality risk was calcu-
lated for all patient visits in the sample, and the dis-
tribution of patient risk was plotted. High-risk
patients were prospectively deﬁned as those with an
expected mortality rate of $10%. Model calibration
was evaluated by plotting the expected versus the
observed mortality in deciles of expected mortality.
Further evaluation of model calibration was per-
formed by plotting the expected versus observed
mortality for the subset of cardiogenic shock and/or
salvage PCI patients, deﬁned as cardiogenic shock at
the start of the procedure, requiring manual com-
pression for cardiac arrest within 10 min of the pro-
cedure start, or the requirement of extracorporeal
hemodynamic support at the beginning of the
procedure.
The hospital-level predicted RAM was then calcu-
lated by combining the patient predicted mortality
risk for all patients treated at a hospital site. The
hospital sites were grouped into risk quintiles by
overall hospital expected mortality; patient charac-
teristics and hospital characteristics were reported for
each quintile. The ratio of observed versus expected
mortality was calculated with 95% conﬁdence in-
tervals (CIs) (based on binomial distribution) for each
quintile of risk. Sensitivity analyses were also per-
formed by repeating this approach with hospitals
ranked in quintiles by the percent of cardiogenic
shock/cardiac arrest patients treated, and by the
percentage of high-risk ($10% predicted mortality)
patients treated.
As a third method of analysis, sites’ highest-risk
cases from a 2-year period (2009 quarter 2 through
2011 quarter 2) were combined into a single year’s
volume to simulate a “concentrated risk year,” and
the hospital sites were used as their own control. This
was done by rank ordering the patients according to
their predicted risk of mortality, selecting the hospi-
tals’ highest-risk cases, and assuming that these
TABLE 1 Baseline Characteristics by Predicted Mortality Quintile
Hospital Risk Groups (Quintiles)
Q1
Highest Q2 Q3 Q4
Q5
Lowest
Age, yrs 64.5  12.4 64.9  12.2 64.8  12.1 64.5  12.0 64.7  11.9
Female 31.5 31.8 32.3 33.2 34.1
Caucasian 87.8 89.6 88.9 87.8 88.7
Prior MI 30.4 31.5 29.8 29.8 28.3
Prior CHF 12.3 12.3 11.3 11.5 11.3
IDDM 12.8 12.6 12.9 13.6 12.9
ESRD (HD) 2.9 2.3 2.3 2.3 1.8
PAD 11.9 12.7 12.4 12.7 12.8
GFR (CG) 73.9  28.8 75.0  29.9 75.6  29.6 75.4  32.0 76.7  31.0
STEMI 24.0 17.8 16.2 13.9 10.6
NYHA IV 6.4 4.8 4.0 3.2 2.0
Shock, 24 h 3.6 2.3 1.8 1.3 0.8
Cardiac arrest 3.2 2.2 1.8 1.4 0.9
Lesion
Left Main 1.7 1.8 1.7 1.8 1.6
Prox. LAD 16.3 15.2 15.0 14.5 14.3
PCI Status
Elective 32.6 39.7 42.6 47.9 60.5
Urgent 41.1 40.8 39.9 37.2 28.3
Emergent 25.5 19.1 17.3 14.8 11.1
Values are mean  SD or %. Baseline characteristics, comorbidities, admission data, and labora-
tory studies, stratiﬁed by Hospital risk Quintile.
CHF ¼ congestive heart failure; ESRD (HD) ¼ end-stage renal disease (hemodialysis);
GFR (CG) ¼ glomerular ﬁltration rate (Cockcroft-Gault); IDDM ¼ insulin-dependent diabetes
mellitus; LVEF ¼ left-ventricular ejection fraction; MI ¼ myocardial infarction; NYHA ¼ New York
Heart Association functional class; PAD ¼ peripheral artery disease; PCI ¼ percutaneous coronary
intervention; Prox. LAD ¼ proximal left anterior descending coronary artery; STEMI ¼ ST-segment
elevation myocardial infarction.
TABLE 2 Hospital Characteristics by Predicted Mortality Quintile
Hospital Risk Groups (Quintiles)
Q1
Highest Q2 Q3 Q4
Q5
Lowest
Bed number 470  241 472  234 494  393 472  240 370  225
PCI volume 591  404 764  406 830  515 1,067  775 1,015  682
Rural 11.7 10.5 14.5 10.3 9.2
Urban 61.8 55.5 55.5 59.6 61.1
Academic 52.0 52.0 49.8 54.5 41.4
Values are mean  SD or %.
PCI ¼ percutaneous intervention.
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13patients were seen in a single year, keeping annual
case volume constant. Observed versus expected
mortality (O/E) ratios were again calculated with 95%
CIs for each quintile based on expected risk. The O/E
ratio in the concentrated risk year scenario was then
plotted against the average O/E ratio during that time
period, with 95% CIs. Centers whose 95% CI for
observed mortality was signiﬁcantly better or worse
than for the predicted mortality were ﬂagged as out-
liers. The frequency of outlier status was then com-
pared between the concentrated risk year and the
overall 2-year period. All statistical analyses were
performed by the Duke Clinical Research Institute
using SAS software (version 9.2, SAS Institute, Cary,
North Carolina). The study was reviewed by the Duke
Institutional Review Board and was determined
to meet the deﬁnition of research not requiring
informed consent, given that patient information is
collected anonymously without unique patient iden-
tiﬁers and only aggregate data are presented and
published.
RESULTS
From January 2010 to December 2010, 647,210 PCI
procedures during 630,377 admissions in 1,208 sites
were registered in the CathPCI registry. After appli-
cation of the aforementioned exclusion criteria,
624,286 PCI procedures in 1,168 sites were included
in the analysis (Figure 1). The CathPCI mortality
model (V4) demonstrated good performance over the
spectrum of risk (from 0.01% to 100%) (Figure 2A).
The model performance seemed equally good when
the same O/E ratios were calculated in the extremely
high-risk subgroups of patients with cardiogenic
shock and/or salvage PCI and in patients at extreme
mortality risk (>10%) (Figure 2B).
The baseline clinical characteristics of the patient
population stratiﬁed by the hospital risk quintiles are
shown in Table 1. Patients at higher-risk hospitals
were of similar age, race, and sex, and had similar
frequency of insulin-dependent diabetes, though
were less likely to have peripheral arterial disease,
cerebrovascular disease, prior congestive heart fail-
ure compared with those in lower-risk hospitals.
However, patients at the highest-risk hospitals were
more likely to have prior myocardial infarction and
to present with ST-segment elevation myocardial
infarction, New York Heart Association functional
class IV heart failure symptoms, shock, or cardiac
arrest. Also, the proportion of PCI procedures at high-
risk hospitals was less likely to be elective, more
likely emergent, and more often involved the prox-
imal left anterior descending coronary artery whencompared with lower-risk hospitals. The hospital-
level characteristics, grouped by hospital risk quin-
tile, are shown in Table 2. High-risk hospitals,
compared with low-risk hospitals, were larger (by bed
number), had a lower annual PCI volume, and were
more likely to be rural or academic centers. There was
substantial variation present in the geographic dis-
tribution of hospitals by risk quintile. A greater pro-
portion of hospitals in the West are in the highest-risk
quintile group, whereas a greater proportion of
Southern hospitals are in the lowest-risk quintile
TABLE 3 Hospitals Predicted Mortality Quintile by Regions
Hospital Risk Groups (Quintiles)
Q1
Highest Q2 Q3 Q4
Q5
Lowest
West (n ¼ 96,764) 23.8 27.5 27.2 14.0 7.4
Northeast (n ¼ 89,723) 12.0 28.6 17.7 22.7 18.5
Midwest (n ¼ 183,540) 12.2 22.9 22.4 24.4 18.1
South (n ¼ 255,333) 8.9 16.0 19.9 28.3 26.8
Values are %.








CI ¼ conﬁdence interval; O
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14group, when compared with the Northeast and Mid-
west regions (Table 3).
On comparison, the O/E ratios for each risk quintile
of hospitals were similar and approximately 1.0,
except for the highest-risk quintile of hospitals, for
which the O/E ratio was 0.91 (95% CI: 0.87 to 0.96),
indicating these hospitals performed better than ex-
pected (Table 4). In addition, when comparing
hospital-level RAM, the highest-risk hospitals had
slightly lower RAM than the lowest-risk hospitals.
A sensitivity analysis, in which hospital sites were
regrouped by frequency of patients with an expected
mortality risk of $10% (Online Table S1) and by the
frequency of cardiogenic shock/ salvage patients
(Online Table S2), found similar results, with the
hospitals’ RAM rates being slightly lower in the
highest-risk hospitals.
As a ﬁnal analysis, we compared the overall per-
formance of the hospitals in an extreme scenario, the
concentrated risk year (Table 5). For all risk quintiles,
the O/E ratio was approximately 1.0 with CIs that
crossed the line of unity, and the agreement of
concentrated risk year O/E with average year O/E was
consistent across nearly all centers (Figure 3). In
addition, during the overall 2009 and 2011 period,
65 (5.4%) centers were ﬂagged as lower-performing
outliers, whereas 48 (4.0%) were classiﬁed as
higher-performing outliers. During the concentrated







(95% CI) RAM (95% CI)
1,168 1.37% 1.37% 1.00 (0.98–1.02) 1.37% (1.34–1.40)
233 2.21% 2.43% 0.91 (0.87–0.96) 1.25% (1.20–1.31)
234 1.63% 1.69% 0.96 (0.92–1.00) 1.32% (1.27–1.38)
234 1.39% 1.36% 1.02 (0.98–1.07) 1.41% (1.34–1.47)
234 1.16% 1.08% 1.07 (1.02–1.12) 1.47% (1.40–1.54)
233 0.81% 0.74% 1.10 (1.03–1.17) 1.51% (1.42–1.60)
/E ratio ¼ observed versus expected mortality ratio; RAM ¼ risk-adjusted mortality.and 45 (3.7%) as higher-performing outliers, indi-
cating no increase in the identiﬁcation of outlier
hospitals when creating a higher-risk annual case mix.
DISCUSSION
There is a growing emphasis to publically report
hospitals’ performance and outcomes from common
diseases. Our study showed the current CathPCI V4
mortality model performed well with good discrimi-
native ability and calibration across the spectrum of
risk. Using this model, we also found that hospitals
treating more high-risk PCI patients did not have
worse outcomes after risk adjustment by this means.
We tested this by comparing observed/expected
mortality in hospitals grouped by 3 different mea-
sures of risk, and concentrating the highest-risk cases
from a 2-year period into 1 year, and subsequently
comparing observed/expected mortality. In both in-
stances, we found no evidence that RAM was worse
when higher-risk patients were included.
HIGH-RISK AND EXTREME-RISK CASES. Previous
investigation raised concerns that even a well-
calibrated model may lack certain variables that are
known to signal the “compassionate use” of PCI and
thus a very high-risk group that could affect RAM
ratings. Resnic et al. (21) studied this question in the
MassDAC (Massachusetts Data Analysis Center) reg-
istry, deﬁning compassionate use as either coma on
presentation for emergent PCI, ventricular assist
device or extracorporeal bypass, or cardiopulmonary
resuscitation at the initiation of the procedure. The
combination and inclusion of these variables into the
standard NCDR CathPCI mortality model did improve
the c-statistic for prediction of mortality (0.87 to
0.90; p < 0.001). However, the number of cases that
qualiﬁed under these compassionate use criteria
was very small, and the authors included a further
analysis of hospital RAM classiﬁcation showing that
inclusion of compassionate use criteria did not
signiﬁcantly change any hospital’s RAM rating.
PHYSICIAN ATTITUDES AND PRACTICES. RAM as a
measure of hospital quality has been criticized in
many ways, but remains a widely reported metric.
Physician survey data reveal concern over the effect
of high-risk cases on hospital and provider RAM es-
timates. Narins et al. (17) published data from a sur-
vey of physicians in New York that indicates 85% of
respondents believed that the RAM model was
insufﬁcient to account for case mix and that nearly
80% of physicians felt that their decision making in
the case of critically ill patients in need of angiog-
raphy or PCI might be affected by the presence of




Year (95% CI) O/E Overall (95% CI) O/E:O/E (95% CI)
Overall 1,204 1.02 (1.00–1.03) 1.00 (0.99–1.02) 1.01 (0.99–1.04)
Top 20% 241 0.98 (0.95–1.00) 0.96 (0.94–0.98) 1.01 (0.98–1.05)
Top 20%–40% 241 1.00 (0.97–1.03) 0.99 (0.96–1.02) 1.01 (0.97–1.06)
Middle 20% 241 1.09 (1.05–1.13) 1.08 (1.04–1.12) 1.01 (0.96–1.06)
Bottom 20%–40% 241 1.09 (1.04–1.14) 1.08 (1.02–1.13) 1.01 (0.94–1.09)
Bottom 20% 240 1.16 (1.07–1.26) 1.15 (1.05–1.24) 1.01 (0.90–1.14)
Abbreviations as in Table 4.
FIGURE 3 Observed/Expected Mortality by Hospital Risk Quintile in a “Concentrated
Risk Year” Versus an Average Year
Observed versus expected mortality (O/E) ratios when the highest-risk cases or concen-
trated into a single year compared with overall O/E ratio in an average year show there is
still a 1:1 relationship at all levels of risk. The 95% conﬁdence intervals are shown with
dotted lines, and a regression line ﬁt to the hospital data shows consistent agreement
between concentrated risk year and average year performance.
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15RAM ratings. These sentiments are borne out in
recently published data from New York and Massa-
chusetts. Moscucci et al. (8) showed that in compar-
ison to Michigan, where there was no system of public
reporting in place, New York patients undergoing PCI
were less likely to have heart failure or cardiogenic
shock and had lower unadjusted mortality rates. The
authors proposed one explanation for this phenome-
non might have been physician reluctance to perform
high-risk cases because of public reporting. McCabe
et al. (18) demonstrated a similar pattern of practice
in Massachusetts soon after statewide mandate of
public reporting of PCI RAM rates. At previously
designated outlier institutions in Massachusetts, pa-
tient risk characteristics were signiﬁcantly lower after
initiation of public reporting than before, again indi-
cating a possible change to risk-averse practices
because of public reporting.
Our study provides no evidence to support these
attitudes and practices. In hospitals across the United
States, those with the highest-risk cases showed no
adverse effect on their RAM. In fact, there was a
signal in our analysis that hospitals that perform the
highest-risk cases, by predicted mortality, may be
outperforming expectations, thus have a lower than
expected RAM. Our study’s results are based on over
600,000 cases from more than 1,150 sites around
the United States, and provided similar results
when hospital’s case mix was risk stratiﬁed using 3
different metrics. In each case, there was no adverse
effect on observed/expected mortality, and RAM was
reduced in the highest-risk hospitals as compared
with the lowest-risk hospitals. Finally, when artiﬁ-
cially creating a year with a very high-risk case mix,
there was consistent site performance and no in-
crease in the number of outlier hospitals identiﬁed in
this population.
CLINICAL IMPLICATIONS. With the expansion of
public reporting in the United States, and the poten-
tial changes in practice patterns because of these
reports, our results have important implications.
Dissemination of these data could potentially reas-
sure practitioners, emphasizing that treating
the highest-risk patients will not adversely affect
RAM ratings. These high-risk patients may be those
that beneﬁt the most from intervention (11,12). Our
results also show signiﬁcant geographic variation in
hospital practice patterns with regard to PCI risk.
Programs of surveillance should be established with
the goal of preventing a further shift in practice to-
wards inappropriate avoidance of high-risk patients,
and providing the highest-quality care across all
geographic regions (4).STUDY LIMITATIONS. Certain factors should be
considered in the interpretation of our study. First,
the CathPCI V4 mortality model was constructed us-
ing data from this time period, and thus would have
validity for our analysis, but may not be generalizable
to all patients undergoing cardiac catheterization.
Also, previous CathPCI-based mortality models may
not have included variables that allowed for accurate
prediction in the highest-risk cases (21). The current
mortality model seems to have addressed these con-
cerns (20). The NCDR CathPCI is a large national
registry that includes community and academic cen-
ters, but may not fully represent practice in all areas
of the United States. However, it is estimated that the
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16NCDR collects data from 85% to 90% of all U.S. cen-
ters and >90% of all PCIs performed (9,19). Finally,
CathPCI is a voluntary program, and thus hospitals
that choose to participate may be more attuned to
quality measures than other hospitals. This also pre-
sents the possibility that hospitals might “up-code”
patient risk to improve quality measures such as O/E
ratios. There is no evidence that this occurred in our
sample population.CONCLUSIONS
We found that the current CathPCI V4 RAM model
accurately predicted mortality in high-risk patientsubgroups and, if anything, overestimated the hazard
in very high-risk patients. We found nothing that
would suggest that altering the current decision
making for treating high-risk patients would result in
worse demonstrated hospital RAM ratings. These
ﬁndings should reassure physicians and could help to
prevent inappropriate risk-avoidant behavior in PCI
practice.
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